Simple counting of nailfold capillary density in suspected systemic sclerosis – 9 years' experience

References

• Maricq H. R., LeRoy E. C. Patterns of finger capillary abnormalities in connective tissue disease by ‘wide‐field’ microscopy. Arthritis Rheum 1973; 6: 619–28
   Google Scholar
• Maricq H. R., LeRoy E. C., D'Angelo W. A., Medsger T. A Jr., Rodnadn G. P., Sharp G. C., et al. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 1980; 23: 183–9
   PubMed Web of Science ®Google Scholar
• Maricq H. R., Weinberger A. B., LeRoy E. C. Early detection of scleroderma‐spectrum disorders by in vivo capillary microscopy. J Rheumatol 1982; 9: 289–91
   PubMedGoogle Scholar
• Lee P., Leung F., Alderdice C., Armstrong S. Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 1983; 10: 930–8
   PubMed Web of Science ®Google Scholar
• Statham B. N., Rowell N. R. Quantification of the nailfold capillary abnormalities in systemic sclerosis and Raynaud's syndrome. Acta Derm Venereol (Stockholm) 1986; 66: 139–43
   PubMedGoogle Scholar
• Ohtsukua T. Quantitative analysis of nailfold capillary abnormalities in patients with connective tissue diseases. Int J Dermatol 1999; 38: 757–64
   PubMedGoogle Scholar
• Cutolo M., Sulli A., Pizzorni C., Accardo S. Nailfold videocapillaroscopy assessment or microvascular damage in systemic sclerosis. J Rheumatol 2000; 1: 155–60
   Google Scholar
• Houtman P., Kallenberg C., Fiedler V., Wouda A. Diagnostic significance of nailfold capillary patterns in patients with Raynaud's phenomenon. J Rheumatol 1986; 13: 556–63
   PubMedGoogle Scholar
• Zufferey P., Depairon M., Chamot A. ‐. M., Monti M. Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma‐pattern abnormalities. A six‐year follow‐up study. Clin Rheumatol 1992; 11: 536–41
   PubMedGoogle Scholar
• Maricq H. R., Spencer‐green G., LeRoy E. C. Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 1976; 61: 862–70
   PubMed Web of Science ®Google Scholar
• Harper F. E., Maricq H. W. R., Turner R. E., Lidman R., Leroy E. C. A prospective study of Raynaud's phenomenon and early connective tissue disease. Am J Med 1982; 72: 883–8
   PubMedGoogle Scholar
• Luggen M., Belhorn L., Evans T., Fitzgerald O., Spencer‐Green G. The evolution of Raynaud's phenomenon: a long‐term prospective study. J Rheumatol 1995; 22: 2226–32
   PubMedGoogle Scholar
• Andersson M. E., Allen P. D., Moore T., Hillier V., Taylor C. J., Herrick A. L. Computerized nailfold video capillaroscopy – a new tool for assessment of Raynaud's phenomenon. J Rheumatol 2005; 32: 841–8
   PubMedGoogle Scholar
• Wildt M., Hesselstrand R., Scheja A., Åkesson A. Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer‐based analysis. Clin Exp Rheumatol 1999; 17: 219–22
   PubMed Web of Science ®Google Scholar
• Scheja A., Åkesson A., Niewierowicz I., Wallin L., Wildt M., Wollheim F. A. Computer‐based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis 1996; 55: 52–6
   PubMed Web of Science ®Google Scholar
• Krutzen E., Bäck S. E., Nilsson‐Ehle I., Nilsson‐Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for assessment of glomerular filtration rate. J Lab Clin Med 1984; 104: 955–61
   PubMed Web of Science ®Google Scholar
• Clements P. J., Lachenbruch P., Seibold J. R., Zee B., Steen V. D., Brennan P., et al. Inter‐ and intraobserver variability of total skin thickness score (modified Rodnad TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281–5
   PubMed Web of Science ®Google Scholar
• Masi A. T., Rodnan G. P., Medsger T. A Jr., Altman R. D., D'Angelo W. A., Fries J. F., et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
   PubMed Web of Science ®Google Scholar
• LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A Jr., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
   PubMed Web of Science ®Google Scholar
• LeRoy C., Medsger T. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573–6
   PubMed Web of Science ®Google Scholar
• Allcock R. J., Forrest I., Corris P. A., Crook P. R., Griffiths I. D. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology 2004; 43: 596–602
   PubMed Web of Science ®Google Scholar
• Wollheim F. A. Classification of systemic sclerosis. Visions and reality. J Reumatol 2005; 44: 1212–16
   Google Scholar
• Buckari M., Hollis S., Moore T., Jayson M. I. V., Herrick A. L. Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy. Rheumatology 2000; 39: 506–12
   PubMedGoogle Scholar
• Cutolo M., Pizzorni C., Tuccio M., Burroni A., Craviotto C., Basso M., et al. Nailfold video capillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatology 2004; 43: 719–26
   PubMed Web of Science ®Google Scholar
• Bredemeier M., Xavier R. M., Copobianco K. G., Restelli V. G., Rohde L. E. P., Pinotti A. F. F., et al. Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 2004; 31: 286–94
   PubMed Web of Science ®Google Scholar
• Lovy M., MacCarter D., Steigerwald J. Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 1985; 28: 496–501
   PubMedGoogle Scholar